Cargando…

Metformin inhibits the proliferation of benign prostatic epithelial cells

OBJECTIVE: Benign prostatic hyperplasia (BPH) is the most common proliferative abnormality of the prostate affecting elderly men throughout the world. Epidemiologic studies have shown that diabetes significantly increases the risk of developing BPH, although whether anti-diabetic medications prevent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zongwei, Xiao, Xingyuan, Ge, Rongbin, Li, Jijun, Johnson, Cameron W., Rassoulian, Cyrus, Olumi, Aria F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333882/ https://www.ncbi.nlm.nih.gov/pubmed/28253329 http://dx.doi.org/10.1371/journal.pone.0173335

Ejemplares similares

Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes
por: Wang, Zongwei, et al.
Publicado: (2012)

Erratum. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes 2012;61:2134–2145
por: Wang, Zongwei, et al.
Publicado: (2021)

Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells
por: Ge, Rongbin, et al.
Publicado: (2015)

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy
por: Wang, Zongwei, et al.
Publicado: (2020)

Self-Retraction Clamp for Dissection of the Posterior Prostatic Fossa During Radical Retropubic Prostatectomy
por: Olumi, Aria F.
Publicado: (2004)

Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
por: Zhang, Bo, et al.
Publicado: (2021)

Inhibiting CBP Decreases AR Expression and Inhibits Proliferation in Benign Prostate Epithelial Cells
por: Tang, Xingxing, et al.
Publicado: (2023)

Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
por: Ge, Rongbin, et al.
Publicado: (2022)

Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells
por: Jung, Yunu, et al.
Publicado: (2017)

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
por: Liu, Deli, et al.
Publicado: (2020)

Correction: Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells
por: Jung, Yunu, et al.
Publicado: (2019)

Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue
por: Vandergrift, Lindsey A., et al.
Publicado: (2018)

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)

GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition
por: Kim, Yejin, et al.
Publicado: (2021)

Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity
por: Yun, Huiyoung, et al.
Publicado: (2015)

Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway
por: Yuan, Yi-Feng, et al.
Publicado: (2020)

Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status
por: Wang, Naitao, et al.
Publicado: (2016)

Sirt1 coordinates with ERα to regulate autophagy and adiposity
por: Tao, Zhipeng, et al.
Publicado: (2021)

Correction: Sirt1 coordinates with ERα to regulate autophagy and adiposity
por: Tao, Zhipeng, et al.
Publicado: (2023)

Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
por: Cheng, Gang, et al.
Publicado: (2019)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Estradiol signaling mediates gender difference in visceral adiposity via autophagy
por: Tao, Zhipeng, et al.
Publicado: (2018)

Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia
por: Liu, Jianmin, et al.
Publicado: (2021)

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
por: Filipovski, Vanja, et al.
Publicado: (2017)

Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
por: Nørgaard, Mette, et al.
Publicado: (2020)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells
por: Chen, Yanbo, et al.
Publicado: (2021)

Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration
por: Zhou, Dong-Ming, et al.
Publicado: (2020)

Three‐dimensional architecture of common benign and precancerous prostate epithelial lesions
por: Verhoef, Esther I, et al.
Publicado: (2019)

The authors reply: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kabir, Ali, et al.
Publicado: (2015)

Stimulation of prostate cells by the senescence phenotype of epithelial and stromal cells: Implication for benign prostate hyperplasia
por: Jiang, Shoulei, et al.
Publicado: (2019)

The preventive effect of metformin on progression of benign prostate hyperplasia: A nationwide population-based cohort study in Korea
por: Hong, Yehee, et al.
Publicado: (2019)

The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo
por: Zhang, Tao, et al.
Publicado: (2013)

Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
por: Kooistra, A., et al.
Publicado: (1995)

Increased Notch signaling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells
por: Kwon, Oh-Joon, et al.
Publicado: (2014)

Cancer-associated fibroblasts of the prostate promote a compliant and more invasive phenotype in benign prostate epithelial cells
por: Jaeschke, A., et al.
Publicado: (2020)

Possible clinical implications of prostate capsule thickness and glandular epithelial cell density in benign prostate hyperplasia
por: Holder, Katherine G., et al.
Publicado: (2021)

Seoritae Extract Reduces Prostate Weight and Suppresses Prostate Cell Proliferation in a Rat Model of Benign Prostate Hyperplasia
por: Jang, Hoon, et al.
Publicado: (2014)

Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic Hyperplasia
por: Cyrus, Ali, et al.
Publicado: (2014)

PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence
por: Clairefond, Sylvie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ck17kpuo5i06bpjkanl4n51kob